COMP <GO>
VCEL vs MRK // ALTMAN Z-SCORE & DEBT/EQUITY
Vericel Corporation (NASDAQ) VS. Merck & Company Inc. (NYSE) • 15-METRIC TALLY: VCEL 4
— MRK 9
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: VCEL
LAST: $42.91 (+4.43%) • MKT CAP: $2.20B
balance-sheet
9.94
LAST: $146.33 (+3.83%) • MKT CAP: $361.02B
balance-sheet
5.19
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VCEL VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | VCEL | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 74.40% | 74.80% | -0.40 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 3.40% | 20.70% | -17.30 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 61.4x | 15.3x | +46.10 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 1.13% | 3.42% | -2.29 | MRK | /fcf-yield <GO> |
| Operating Margin | 4.00% | 34.30% | -30.30 | MRK | /operating-margins <GO> |
| Net Profit Margin | 6.00% | 28.10% | -22.10 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 16.50% | 1.30% | +15.20 | VCEL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 9.94 | 5.19 | +4.75 | VCEL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | VCEL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.0 | 51.7 | +4.30 | VCEL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 111.7x | 18.4x | +93.30 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.20B | $361.02B | -$358.82B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | VCEL REV | MRK REV | VCEL GROSS % | MRK GROSS % | VCEL FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $276.3M | $65.01B | 74.4% | 74.8% | $24.7M | $12.36B |
| FY 2024 | $237.2M | $64.17B | 72.6% | 76.3% | -$5.8M | $18.10B |
| FY 2023 | $197.5M | $60.12B | — | — | $35.3M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VCEL // BETA —
MRK // BETA 0.92